FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

34621511000001109: Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Aug 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104700901000001115 Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104701001000001112 Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Is a Olaratumab 190mg/19ml solution for infusion vials true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has active ingredient Monoclonal antibody true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient Olaratumab false Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Is a Lartruvo true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has specific active ingredient Olaratumab true Inferred relationship Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Has manufactured dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial Has AMP True Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start